GSAM 2024 Annual Conference

No products in the cart.

GSAM 2024 Annual Conference

No products in the cart.

Articles of Interest

Home Archive "Articles of Interest"
Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data
Articles of Interest

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data

Abstract Background: Reports of reduced desire to smoke in patients treated with semaglutide, a glucagon-like peptide receptor agonist (GLP-1RA) medication for type 2 diabetes mellitus (T2DM) and obesity, have raised interest about its potential benefit for tobacco use disorders (TUDs). Objective: To examine the association of semaglutide with TUD-related health care measures in...
Overdose Deaths are declining: But Not in Black Communities
Articles of Interest Education Legislation

Overdose deaths are declining. But Not in Black Communities

For years, we’ve read saddening stories in newspapers like this one about the horrific effects of the overdose crisis on Hoosiers. Stories about lives lost, families torn apart and communities grieving. But in mid-May, we read a story that wasn’t sad. A story that gave us hope. The Centers for Disease Control and Prevention revealed preliminary 2023 data showing overdose deaths...
Position Statement on Access to Evidence-Based Treatment for Opioid Use Disorder
Articles of Interest Legislation

Position Statement on Access to Evidence-Based Treatment for Opioid Use Disorder

Summary: The Federation of State Medical Boards (FSMB) has released a Position Statement on Access to Evidence-Based Treatment for Opioid Use Disorder, emphasizing the ongoing opioid overdose crisis in the United States, which saw over 107,000 deaths in 2022 despite declining prescription rates for opioid analgesics. The statement highlights the low treatment rates with Medications...
Articles of Interest

Providers Clinical Support Systems: Medications for Alcohol Use Disorder:

The website for the Providers Clinical Support System – Medications for Alcohol Use Disorder (PCSS-MAUD) is a national initiative funded by the Substance Abuse and Mental Health Services Administration (SAMHSA). It offers free training, guidance, and mentoring aimed at enhancing the skills of healthcare professionals in the prevention, diagnosis, and treatment of alcohol use...
Disparities in Overdose Deaths: Looking Back at Larochelle and Colleagues’ 2021 Paper:
Articles of Interest Editorials

Disparities in Overdose Deaths: Looking Back at Larochelle and Colleagues’ 2021 Paper

EDITORIAL: APH Disparities in Overdose Deaths: Looking Back at Larochelle and Colleagues’ 2021 Paper By Nora D. Volkow, MD, Beth Han, PhD, MD, MPH, and Redonna K Chandler, PhD About the Authors: All authors are with the National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD. The opioid overdose crisis, initially most heavily affecting non-Hispanic...
Barriers to Opioid Use Disordeer Treatment Among People who use drugs in the rural United States: A Qualitative, Multi-site study.
Articles of Interest Education

Barriers to Opioid Use Disordeer Treatment Among People who use drugs in the rural United States: A Qualitative, Multi-site study.

Abstract Background In 2020, 2.8 million people required substance use disorder (SUD) treatment in nonmetropolitan or ‘rural’ areas in the U.S. Among this population, only 10% received SUD treatment from a specialty facility, and 1 in 500 received medication for opioid use disorder (MOUD). We explored the context surrounding barriers to SUD treatment in the rural United...
Neurodevelpmental Outcomes in Infants Prenatally Exposed to Substance Use
Articles of Interest Education

Evaluation of Three-year Neurodevelopmental Outcomes in Infants Prenatally Exposed to Substance Use

Abstract Introduction Prenatal exposure to substance use is associated with long-term deficits in the neurodevelopment of children. The objective was to investigate the association between cognitive, motor, and language neurodevelopment at three years of age in infants prenatally exposed to substance use. Material and methods A prospective matched case-control study was...
Public Policy Statement on Government Strategies to Foster Ethical Addiction Treatment
Articles of Interest Legislation

Public Policy Statement on Government Strategies to Foster Ethical Addiction Treatment

Last night, the ASAM Board of Directors approved the Public Policy Statement on Government Strategies to Foster Ethical Addiction Treatment. Congratulations, and to the writing committee, especially! View the Documents BelowGovernment Strategies to Foster Ethical Addiction Treatment Introduction America is at a crossroads with confronting addiction, which is one of...
ASAM Applauds Senate Committee for Advancing SUPPORT Act Reauthorization and the Modernizing Opioid Treatment Access Act
Articles of Interest

ASAM Applauds Senate Committee for Advancing SUPPORT Act Reauthorization and the Modernizing Opioid Treatment Access Act:

FOR IMMEDIATE RELEASE December 12, 2023   Rockville, MD – Today, the American Society of Addiction Medicine (ASAM) applauded the Senate Health, Education, Labor and Pensions (HELP) Committee for advancing the SUPPORT for Patients and Communities Reauthorization Act (S. 3393). ASAM also applauded the committee for advancing the Modernizing Opioid Treatment Access Act (S. 644),...
ASAM Provides Comments to HHS on Insurance Coverage of Preventive Services
Articles of Interest Legislation

ASAM Provides Comments to HHS on Insurance Coverage of Preventive Services

In response to a request for comments from the U.S. Department of Health and Human Services (HHS) regarding insurance coverage of preventive services provided over the counter (OTC), ASAM supported removing barriers to smoking cessation products to provide more people better access to these tools. In addition, ASAM encouraged HHS to consider the important role of clinicians in...